Cam Gallagher
President at Zentalis Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 3 years.
Zentalis Pharmaceuticals Inc.
Director · President, Interim CFO
Opus Genetics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Opus Genetics Inc. | Grant or award | +24,367 | — | — |
| Jan 6, 2026 | Opus Genetics Inc. | Grant or award | +67,000 | — | — |
| Dec 31, 2025 | Opus Genetics Inc. | Grant or award | +33,000 | — | — |
| Dec 29, 2025 | Opus Genetics Inc. | Open-market purchase | +81,000 | $1.98 | $160,380 |
| Dec 29, 2025 | Opus Genetics Inc. | Open-market purchase | +83,000 | $1.97 | $163,510 |
| Aug 25, 2025 | Opus Genetics Inc. | Grant or award | +869,565 | $1.15 | $1,000,000 |
| Apr 30, 2025 | Opus Genetics Inc. | Grant or award | +79,504 | — | — |
| Mar 24, 2025 | Opus Genetics Inc. | Grant or award | +784,314 | — | — |
| Jun 11, 2024 | Opus Genetics Inc. | Grant or award | +41,143 | — | — |
| May 31, 2024 | Zentalis Pharmaceuticals Inc. | Open-market sale | −9,597 | $11.98 | $114,972 |
| Feb 12, 2024 | Zentalis Pharmaceuticals Inc. | Open-market sale | −1,173 | $11.44 | $13,419 |
| Feb 2, 2024 | Zentalis Pharmaceuticals Inc. | Open-market sale | −11,552 | $11.54 | $133,310 |
| Feb 1, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +192,500 | — | — |
| Jun 6, 2023 | Opus Genetics Inc. | Grant or award | +10,976 | — | — |
| May 31, 2023 | Zentalis Pharmaceuticals Inc. | Open-market sale | −9,242 | $26.40 | $243,989 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.